EU approves €400M German aid to Sanofi for insulin supply resilience

The European Commission approved a €400 million German State aid measure compensating Sanofi for maintaining insulin production as a service of general economic interest. This is a policy response to prior insulin shortages, aiming to secure domestic supply. The move signals EU-level support for strategic pharmaceutical manufacturing resilience.